Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Julian H Elliott"'
Autor:
Toshi A Furukawa, Andrea Cipriani, Edoardo Giuseppe Ostinelli, Georgia Salanti, Malcolm Macleod, Emily Sena, James Thomas, Miranda Wolpert, Susan Michie, Jennifer Potts, Matthias Egger, Soraya Seedat, Stefan Leucht, Virginia Chiocchia, Karla Soares-Weiser, Robert McCutcheon, Ayse Kurtulmus, David Gilbert, Sophie Chung, Spyridon Siafis, Carmen Moreno, Lea Milligan, Janna Hastings, Parisa Mansoori, James M Barker, Simonne Wright, Matilda Simpson, Olufisayo Elugbadebo, Thomy Tonia, Rania Elgarf, Ouma Simple, Niall Boyce, Anjuli Sharma, Julian H Elliott
Publikováno v:
BMJ Mental Health, Vol 26, Iss 1 (2023)
In anxiety, depression and psychosis, there has been frustratingly slow progress in developing novel therapies that make a substantial difference in practice, as well as in predicting which treatments will work for whom and in what contexts. To inter
Externí odkaz:
https://doaj.org/article/044de1dd54964197a4947ffbff17d6d6
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0269482 (2022)
BackgroundSince COVID-19 was first recognised, there has been ever-changing evidence and misinformation around effective use of medicines. Understanding how pandemics impact on medicine use can help policymakers act quickly to prevent harm. We quanti
Externí odkaz:
https://doaj.org/article/7c8271ad58464e9890f568c07ff542c6
Autor:
Nicholas A Medland, Eric P F Chow, James H McMahon, Julian H Elliott, Jennifer F Hoy, Christopher K Fairley
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177634 (2017)
The HIV care cascade is increasingly used to evaluate HIV treatment programs at the population level. However, the cascade indicators lack the ability to show changes over time, which reduces their utility to guide health policy. Alternatives have be
Externí odkaz:
https://doaj.org/article/4563712fc32c4230b7f0b9789cf47dde
Publikováno v:
Bulletin of the World Health Organization, Vol 91, Iss 5, Pp 377-385 (2013)
OBJECTIVE: To establish estimates of viral suppression in low- and middle-income countries (LMICs) in patients who received antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection. METHODS: Data on viral suppression after 12 mon
Externí odkaz:
https://doaj.org/article/34e4acc0183a4c0b8f24558b3930e937
Autor:
Michelle K Yong, Paul U Cameron, Tim Spelman, Julian H Elliott, Christopher K Fairley, Jeffrey Boyle, Misato Miyamasu, Sharon R Lewin
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0166549 (2016)
HIV infection is characterised by persistent immune dysfunction of both the adaptive and innate immune responses. The aim of this study was to evaluate these responses using a novel high throughput assay in healthy controls and HIV-infected individua
Externí odkaz:
https://doaj.org/article/9864686ba9ad4b0e9a2cf3521c876c27
Publikováno v:
PLoS Pathogens, Vol 11, Iss 10, p e1005237 (2015)
Recent efforts to cure human immunodeficiency virus type-1 (HIV-1) infection have focused on developing latency reversing agents as a first step to eradicate the latent reservoir. The histone deacetylase inhibitor, vorinostat, has been shown to activ
Externí odkaz:
https://doaj.org/article/feeea8ff1707487dac806f641f8eaf5c
Autor:
Julian H Elliott, Fiona Wightman, Ajantha Solomon, Khader Ghneim, Jeffrey Ahlers, Mark J Cameron, Miranda Z Smith, Tim Spelman, James McMahon, Pushparaj Velayudham, Gregor Brown, Janine Roney, Jo Watson, Miles H Prince, Jennifer F Hoy, Nicolas Chomont, Rémi Fromentin, Francesco A Procopio, Joumana Zeidan, Sarah Palmer, Lina Odevall, Ricky W Johnstone, Ben P Martin, Elizabeth Sinclair, Steven G Deeks, Daria J Hazuda, Paul U Cameron, Rafick-Pierre Sékaly, Sharon R Lewin
Publikováno v:
PLoS Pathogens, Vol 10, Iss 10, p e1004473 (2014)
UnlabelledHuman immunodeficiency virus (HIV) persistence in latently infected resting memory CD4+ T-cells is the major barrier to HIV cure. Cellular histone deacetylases (HDACs) are important in maintaining HIV latency and histone deacetylase inhibit
Externí odkaz:
https://doaj.org/article/b6cb4c8618164166ada773318ee06d1f
Autor:
Julian H Elliott, Tari Turner, Ornella Clavisi, James Thomas, Julian P T Higgins, Chris Mavergames, Russell L Gruen
Publikováno v:
PLoS Medicine, Vol 11, Iss 2, p e1001603 (2014)
The current difficulties in keeping systematic reviews up to date leads to considerable inaccuracy, hampering the translation of knowledge into action. Incremental advances in conventional review updating are unlikely to lead to substantial improveme
Externí odkaz:
https://doaj.org/article/8607f0c7a9e04b76bbf74150eef39ab2
Autor:
Catherine S Marshall, Andrea J Curtis, Tim Spelman, Daniel P O'Brien, Jane Greig, Leslie Shanks, Philipp du Cros, Esther C Casas, Marcio Silveira da Fonseca, Eugene Athan, Julian H Elliott
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68445 (2013)
OBJECTIVES: To identify associations between specific WHO stage 3 and 4 conditions diagnosed after ART initiation and all cause mortality for patients in resource-limited settings (RLS). DESIGN, SETTING: Analysis of routine program data collected pro
Externí odkaz:
https://doaj.org/article/660179d08a074492ba7e07ce9ba792a1
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56047 (2013)
A large proportion of patients receiving antiretroviral therapy (ART) in low and middle income countries (LMICs) have unknown treatment outcomes and are classified as lost to follow-up (LTFU). Physical tracing of patients classified as LTFU is common
Externí odkaz:
https://doaj.org/article/170736d778cc48bbb553f5c4dd4285a6